Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec;11(4):1526-40.
doi: 10.1208/s12249-010-9526-5. Epub 2010 Oct 26.

Injectable lipid emulsions-advancements, opportunities and challenges

Affiliations
Review

Injectable lipid emulsions-advancements, opportunities and challenges

Ketan Hippalgaonkar et al. AAPS PharmSciTech. 2010 Dec.

Abstract

Injectable lipid emulsions, for decades, have been clinically used as an energy source for hospitalized patients by providing essential fatty acids and vitamins. Recent interest in utilizing lipid emulsions for delivering lipid soluble therapeutic agents, intravenously, has been continuously growing due to the biocompatible nature of the lipid-based delivery systems. Advancements in the area of novel lipids (olive oil and fish oil) have opened a new area for future clinical application of lipid-based injectable delivery systems that may provide a better safety profile over traditionally used long- and medium-chain triglycerides to critically ill patients. Formulation components and process parameters play critical role in the success of lipid injectable emulsions as drug delivery vehicles and hence need to be well integrated in the formulation development strategies. Physico-chemical properties of active therapeutic agents significantly impact pharmacokinetics and tissue disposition following intravenous administration of drug-containing lipid emulsion and hence need special attention while selecting such delivery vehicles. In summary, this review provides a broad overview of recent advancements in the field of novel lipids, opportunities for intravenous drug delivery, and challenges associated with injectable lipid emulsions.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Key unit operations for preparing lipid emulsions
Fig. 2
Fig. 2
A schematic depicting drug distribution within the emulsion system

References

    1. Vinnars E, Hammarqvist F. 25th Arvid Wretlind’s Lecture—Silver anniversary, 25 years with ESPEN, the history of nutrition. Clin Nutr. 2004;23:955–62. doi: 10.1016/j.clnu.2004.06.001. - DOI - PubMed
    1. Wretlind A. Development of fat emulsions. JPEN J Parenter Enteral Nutr. 1981;5:230–5. doi: 10.1177/0148607181005003230. - DOI - PubMed
    1. Vinnars E, Wilmore D. Jonathan roads symposium papers. History of parenteral nutrition. JPEN J Parenter Enteral Nutr. 2003;27:225–31. doi: 10.1177/0148607103027003225. - DOI - PubMed
    1. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009;33:541–7. doi: 10.1177/0148607109332773. - DOI - PubMed
    1. Raghunathji NB, Albert EC, Madurai G, Charles ES, inventors; Emulsion compositions for the parenteral and/or oral administration of sparingly water soluble ionizable hydrophobic drugs patent EP0215313. 1992.

MeSH terms